State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome
Charlan D. Kroelinger(National Center for Chronic Disease Prevention and Health Promotion), Wanda D. Barfield(National Center for Chronic Disease Prevention and Health Promotion), Hadley R. Hickner(Substance Abuse and Mental Health Services Administration), Marion E. Rice, Mary Kate Weber(Centers for Disease Control and Prevention), Carrie K. Shapiro‐Mendoza(Emory University), Margaret A. Honein(National Center on Birth Defects and Developmental Disabilities), S. Nicole Fehrenbach(Substance Abuse and Mental Health Services Administration), Donna Addison(Substance Abuse and Mental Health Services Administration), Lisa Romero(National Center for Chronic Disease Prevention and Health Promotion), Trish Mueller(Substance Abuse and Mental Health Services Administration), Shanna Cox(National Center for Chronic Disease Prevention and Health Promotion), Jean Y. Ko(National Center for Chronic Disease Prevention and Health Promotion)
Cited by 63
Related Papers
H1N1 2009 influenza virus infection during pregnancy in the USA
|The Lancet|2009|1.4k
Racial/Ethnic Disparities in Pregnancy-Related Deaths — United States, 2007–2016
|MMWR Morbidity and Mortality Weekly Report|2019|867
<i>Vital Signs:</i> Pregnancy-Related Deaths, United States, 2011–2015, and Strategies for Prevention, 13 States, 2013–2017
|MMWR Morbidity and Mortality Weekly Report|2019|804
Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy
|JAMA|2016|781
Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization — United States, 2017–2019
|MMWR Morbidity and Mortality Weekly Report|2022|442